IQLT - ETF AI Analysis

Top Page

iShares MSCI Intl Quality Factor ETF (IQLT)

Rating:68Neutral

Price Target:―

The iShares MSCI Intl Quality Factor ETF (IQLT) benefits from strong contributions by holdings like Novartis AG and AstraZeneca, which showcase robust financial performance, stable growth, and positive earnings sentiment. However, weaker technical momentum in stocks such as Allianz and Shell, along with valuation concerns in some holdings, slightly dampen the overall rating. Investors should note the ETF's exposure to multiple sectors, which helps diversify risk but may also limit concentrated gains.

Positive Factors

Strong Top Holdings

Several of the largest positions, such as ASML Holding NV and Nestlé SA, have delivered strong year-to-date performance, supporting the ETF's overall returns.

Global Diversification

The ETF invests across multiple countries, including the UK, Switzerland, Japan, and others, reducing reliance on any single economy.

Reasonable Expense Ratio

With an expense ratio of 0.3%, the fund offers relatively low costs compared to actively managed alternatives.

Negative Factors

Underperforming Holding

LVMH Moet Hennessy Louis Vuitton, one of the top holdings, has shown negative year-to-date performance, which could drag on the fund's returns.

Sector Concentration in Financials

The ETF has significant exposure to the financial sector, which may increase vulnerability to sector-specific risks.

Limited U.S. Exposure

With only 5.56% of assets allocated to U.S. companies, the fund may miss out on opportunities in the world's largest economy.

IQLT vs. SPDR S&P 500 ETF (SPY)

AUM13.85B

RegionDeveloped Markets

Expense Ratio0.30%

Beta0.70

IssueriShares

Inception DateJan 13, 2015

Dividend Yield2.28%

Asset ClassEquity

Index TrackedWorld ex USA Sector Neutral Quality

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume1,305,278

30 Day Avg. Volume2,336,024

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

49.64

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering294

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

IQLT Summary

The iShares MSCI Intl Quality Factor ETF (IQLT) is an investment fund that focuses on high-quality companies from developed markets outside the U.S. It includes businesses with strong financial health, stable earnings, and solid profitability. Some well-known companies in this ETF are Nestlé and Roche Holding AG. By investing in IQLT, you can diversify your portfolio internationally while targeting companies with a proven track record of resilience and efficiency. However, since it invests in global markets, its performance can be affected by international economic conditions and currency fluctuations.

How much will it cost me?The iShares MSCI Intl Quality Factor ETF (IQLT) has an expense ratio of 0.30%, which means you’ll pay $3 per year for every $1,000 invested. This is slightly higher than average for passively managed ETFs because it focuses on a specific strategy of selecting high-quality international stocks, which requires more specialized research and management.

What would affect this ETF?The iShares MSCI Intl Quality Factor ETF (IQLT) could benefit from continued global economic growth and increased demand for high-quality companies in developed markets outside the U.S., particularly in sectors like financials, technology, and healthcare. However, it may face challenges from rising interest rates, which could pressure profitability in certain sectors, and geopolitical risks or regulatory changes in key regions that could impact its top holdings like ASML, Shell, and Nestlé. Diversification across sectors and countries helps mitigate some risks but does not eliminate them entirely.

IQLT Top 10 Holdings

The iShares MSCI Intl Quality Factor ETF (IQLT) leans heavily on financials and industrials, with notable contributions from healthcare and technology. Roche and Novartis are rising stars, benefiting from strong pipelines and steady growth, while ASML Holding adds a tech-driven spark with its robust profitability. On the flip side, Shell and Nestlé are lagging slightly, facing short-term challenges despite their solid fundamentals. With a focus on developed markets outside the U.S., this fund offers a global mix, but its concentration in quality-driven sectors keeps the spotlight on resilience and long-term potential.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
ASML	ASML Holding NV	5.37%	$741.86M	€413.15B	48.58%	76 Outperform
ALV	Allianz	2.58%	$355.71M	€144.77B	27.96%	67 Neutral
ROG	Roche Holding AG	2.36%	$326.65M	CHF272.24B	45.48%	73 Outperform
NOVN	Novartis AG	2.26%	$311.75M	CHF217.04B	25.19%	80 Outperform
AZN	AstraZeneca	2.13%	$294.12M	£220.41B	29.45%	80 Outperform
SHEL	Shell (UK)	2.11%	$291.38M	£150.06B	0.57%	73 Outperform
NESN	Nestlé SA	1.92%	$265.12M	CHF190.59B	15.67%	71 Outperform
ZURN	Zurich Insurance Group	1.77%	$243.95M	CHF82.21B	24.89%	78 Outperform
ABB	ABB Ltd	1.76%	$242.83M	kr1.26T	20.79%	78 Outperform
	―	1.55%	$213.78M	―	―	―

IQLT Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

44.70

Positive

100DMA

44.14

Positive

200DMA

42.62

Positive

Market Momentum

MACD

0.50

Negative

RSI

64.04

Neutral

STOCH

79.90

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IQLT, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 45.54, equal to the 50-day MA of 44.70, and equal to the 200-day MA of 42.62, indicating a bullish trend. The MACD of 0.50 indicates Negative momentum. The RSI at 64.04 is Neutral, neither overbought nor oversold. The STOCH value of 79.90 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IQLT.

IQLT Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
IQLT	―	―	$13.85B	0.30%	―
VEA	―	―	$197.96B	0.03%	―
SCHF	―	―	$56.70B	0.03%	―
SPDW	―	―	$34.32B	0.03%	―
IDEV	―	―	$24.94B	0.04%	―
DFAI	―	―	$13.17B	0.18%	―

Performance Comparison

IQLT

iShares MSCI Intl Quality Factor ETF

46.32

10.29

28.56%

VEA

Vanguard FTSE Developed Markets ETF

―

SCHF

Schwab International Equity ETF

―

SPDW

SPDR Portfolio Developed World ex-US ETF

―

IDEV

iShares Core MSCI International Developed Markets ETF

―

DFAI

Dimensional International Core Equity Market ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents